Do Lipomas Show Up on an Ultrasound?

Lipomas do show up on ultrasound, and ultrasound is typically the first imaging tool a doctor reaches for when evaluating a soft lump under the skin. On the screen, a lipoma usually appears as a well-defined, oval or spindle-shaped mass with characteristic internal lines running through it. A systematic review of the diagnostic evidence found that ultrasound picks up lipomas with a sensitivity of about 87% and correctly rules out non-lipomas with a specificity of roughly 96%, making it a strong first-line test for most people with a suspicious bump.

What a Lipoma Looks Like on Ultrasound

Lipomas are not invisible blobs on an ultrasound image. They have recognizable patterns that experienced sonographers and radiologists learn to spot. A study of 52 pathologically confirmed lipomas identified four distinct sonographic patterns. The most common was a well-organized mass with mixed brightness and multiple clearly defined, long, smooth internal lines running parallel to the long axis of the lump. The second pattern was a more disorganized mix of bright and dark areas with some irregular, broken-up internal lines. A third pattern appeared mostly bright with scattered irregular lines, and the least common was a relatively uniform bright mass with short, fragmented internal lines.¹

Those internal lines correspond to the thin fibrous bands, or septa, that run through fatty tissue. Because fat and fibrous tissue reflect sound waves differently, the alternating layers create a striped or layered look that is fairly distinctive to lipomas. This internal architecture is one of the key reasons ultrasound works well for these tumors: fat has a recognizable “texture” on ultrasound that other soft tissue masses lack.

Size matters for visibility. Small lipomas close to the skin surface tend to image more clearly than larger or deeper ones, partly because the ultrasound probe can sit right on top of them and partly because deeper structures require lower-frequency sound waves that sacrifice some detail. That said, even deep-seated lipomas can be identified. A study specifically examining deep lipomas found that most had well-defined margins and the expected internal architecture, though over 40% showed at least some blood flow inside the mass on Doppler imaging.²

How Accurately Does Ultrasound Diagnose a Lipoma?

Accuracy depends on what you mean. If the question is “can ultrasound tell that this lump is a lipoma and not something else entirely,” the answer is reassuringly good. The systematic review pooling data across six studies found about 87% sensitivity and 96% specificity.³ In practical terms, that means ultrasound correctly identifies most lipomas as lipomas and rarely calls something a lipoma when it is not.

Ultrasound also performs far better than physical examination alone. One study directly compared the two and found that sensitivity for detecting lipomas jumped from about 55% after palpation alone to about 88% after ultrasound. At the same time, specificity stayed extremely high at over 99%.⁴ So if your doctor pokes at a lump and says “it’s probably a lipoma,” adding an ultrasound substantially increases the confidence in that guess.

There is a wrinkle, though. Not every study reports the same level of confidence. One study that had three independent radiologists review ultrasound images of soft tissue lipomas against pathology results found sensitivities of only 40% to 52%, with accuracies in the range of 49% to 64%.⁵ The difference likely reflects how “accuracy” is defined in each study and the specific mix of tumors in the sample. When the comparison group includes a lot of tumors that closely mimic lipomas, the job gets harder. The broader systematic review, which pooled results across multiple studies and populations, gives a more balanced picture than any single study.

The Real Worry: Can Ultrasound Tell a Lipoma from a Liposarcoma?

This is the question most people are actually anxious about when they search for information on lipoma imaging. Liposarcomas are malignant fatty tumors, and some low-grade forms can look strikingly similar to benign lipomas on imaging. The honest answer is that ultrasound can raise suspicion but cannot definitively rule out malignancy in every case.

A study comparing the ultrasound features of well-differentiated liposarcomas to benign lipomas found that both types shared well-defined margins and mixed internal brightness, including those typical fine internal lines. However, liposarcomas were significantly more likely to be deep, irregularly shaped, larger, brighter than the surrounding tissue, and to show blood flow on Doppler.⁶ Each of these features, individually, is not a slam dunk. Plenty of benign lipomas are deep or large. But when several suspicious features cluster together, the radiologist’s concern appropriately rises.

A research group studying clinical, ultrasound, and MRI signs found that among all the traditional “red-flag” markers for malignancy, only the depth of the tumor as measured by ultrasound emerged as a significant predictor of whether a fatty mass turned out to be non-benign after surgery. The combined information from ultrasound and clinical exam was actually more predictive of the final pathology result than MRI alone.⁷ That finding surprised many clinicians, because MRI has long been considered the gold standard for soft tissue tumor evaluation.

Doppler and Blood Flow Clues

Standard ultrasound shows you structure. Doppler ultrasound adds information about blood flow inside the mass, and this turns out to be one of the more useful clues for separating worrisome lumps from harmless ones. Among deep-seated lipomas, roughly 57% showed no internal blood flow at all, about 12% showed minimal flow, and around 31% showed mild flow.² Most benign lipomas are relatively quiet in terms of vascularity.

By contrast, the presence of blood vessels running through a fatty mass is one of the features significantly more common in well-differentiated liposarcomas than in benign lipomas.⁶ A lump that is avascular on Doppler is reassuring. A lump with obvious internal blood flow is not necessarily malignant, but it warrants closer attention.

Advanced Ultrasound Techniques

Researchers have been testing whether newer ultrasound technologies can improve the ability to sort benign lipomas from liposarcomas. Two approaches have received the most attention: elastography and contrast-enhanced ultrasound.

Elastography measures how stiff a tissue is by sending shear waves through it. The theory is that malignant tumors tend to be stiffer than benign ones, so you could set a stiffness cutoff and sort tumors accordingly. In practice, the results have been disappointing for fatty tumors specifically. A study evaluating shear wave elastography for distinguishing lipomas from low-to-intermediate-grade liposarcomas found that stiffness measurements poorly predicted malignancy, with the test performing barely better than a coin flip. Using a previously proposed stiffness threshold, the test misclassified about one in ten liposarcomas as benign.⁸ For now, elastography does not add much to the standard ultrasound evaluation of fatty lumps.

Contrast-enhanced ultrasound, which involves injecting tiny gas-filled bubbles into a vein and watching how they flow through the tumor, has shown more promise. One study found significantly higher blood flow levels in liposarcomas compared to both benign lipomas and borderline atypical lipomatous tumors.⁹ Another study looking specifically at benign lipomas versus atypical lipomatous tumors found that even these harder-to-distinguish categories had significantly different perfusion patterns. The borderline tumors showed higher peak blood flow and faster filling times than straightforward lipomas.¹⁰

A comparison of contrast-enhanced ultrasound and contrast-enhanced MRI for soft tissue tumors found that the two performed similarly. Contrast-enhanced ultrasound achieved about 88% sensitivity and 67% specificity for sorting benign from malignant tumors, while contrast-enhanced MRI hit about 89% sensitivity and 60% specificity.¹¹ The ultrasound approach actually had a slight edge in specificity, though the numbers are close enough that calling one clearly superior is premature. Contrast-enhanced ultrasound is still not routine in most clinics for lipoma evaluation, but the evidence is building.

When Your Doctor Might Still Want an MRI

Given the research showing that ultrasound and clinical examination combined can outperform MRI for distinguishing benign from non-benign fatty tumors, you might wonder why MRI is still part of the workup. The answer lies in what happens after the diagnosis. MRI excels at mapping the exact extent of a tumor, its relationship to surrounding muscles, nerves, and blood vessels, and whether it has invaded nearby structures. That information is critical for surgical planning but less important for the initial “is this something to worry about” question.

The Welsh Sarcoma Service, cited in the same study, has moved toward rapid-access screening clinics that combine clinical and ultrasound evaluation upfront, reserving MRI for cases where surgery is being considered or where ultrasound findings raise genuine concern.¹² This approach saves time and cost without sacrificing diagnostic quality for the initial triage. If your ultrasound shows a textbook-looking superficial lipoma with no worrisome features, jumping straight to MRI adds expense but rarely changes the diagnosis.

That said, certain features on ultrasound should trigger further workup. A mass that is deep to the muscle layer, larger than about 5 cm, growing rapidly, irregularly shaped, or showing significant internal blood flow on Doppler deserves a closer look. In those cases, MRI and possibly a biopsy become appropriate next steps.

Ultrasound-Guided Biopsy

When imaging alone cannot settle the question, ultrasound serves a second role: guiding a biopsy needle into the mass in real time. This allows a pathologist to examine actual tissue under a microscope, which remains the definitive way to distinguish a benign lipoma from a liposarcoma.

A study of image-guided core needle biopsy for fatty tumors found excellent overall concordance between the biopsy diagnosis and the final diagnosis after surgical removal, at 95%. For straightforward benign lipomas and higher-grade liposarcomas, the concordance was 100%. The weak spot was borderline tumors: about 19% of masses initially called atypical lipomatous tumors on biopsy were upgraded to a more aggressive diagnosis after the whole tumor was removed and fully examined.¹³ This limitation is inherent to needle biopsy: the needle only samples a small piece of the mass, and if the more aggressive area is elsewhere, it can be missed.

Still, for the vast majority of people who have a soft, painless lump under the skin, the combination of clinical examination, standard ultrasound, and occasionally a guided biopsy is enough to reach a confident diagnosis without surgery.

Angiolipomas Look Different

Not all lipomas are the same under the ultrasound probe. Angiolipomas, a common variant that contains a significant vascular component along with fat, have a distinctly different ultrasound appearance from ordinary superficial lipomas. A study comparing the two found that angiolipomas frequently appeared brighter, more heterogeneous, and more oval-shaped, with fewer visible capsules along their sides. Standard superficial lipomas, by contrast, tended to be more uniform in brightness, spindle-shaped, and had well-visible capsules.¹⁴

This matters clinically because angiolipomas tend to be painful, which is unusual for standard lipomas. If someone has a painful subcutaneous lump that looks bright and heterogeneous on ultrasound, an angiolipoma diagnosis makes more sense than a standard lipoma. Another study of angiolipomas found that all cases were brighter than surrounding tissue, about 55% were heterogeneous, and only 23% showed visible blood flow, despite being defined by their vascular content.¹⁵ The vascular channels in angiolipomas are often too small for Doppler to detect, which is a useful reminder that the absence of Doppler signal does not always mean the absence of vessels.

Ultrasound for Lipomas in Children

In children, ultrasound is especially well-suited as a first-line imaging tool for soft tissue lumps because it requires no sedation, no radiation, and no contrast injection. The vast majority of superficial soft tissue masses in kids are benign, and ultrasound can often distinguish common entities from one another based on location, internal structure, vascularity, and how much the mass compresses when pressed with the probe.¹⁶ Lipomas are less common in young children than in adults, so when a pediatric patient does present with a fatty-appearing lump, the ultrasound characteristics become especially important for confirming the diagnosis and ruling out other possibilities.

The same general principles apply in pediatric imaging: a well-defined, compressible, avascular mass with characteristic internal lines is reassuring. Anything atypical in a child, such as rapid growth, deep location, or unusual internal features, warrants the same escalation to MRI or biopsy that it would in an adult.

Practical Takeaways If You Have a Lump

If you find a soft, mobile lump under your skin, the most common path is a visit to your doctor, a physical exam, and then an ultrasound if there is any uncertainty. The ultrasound is quick, painless, widely available, and does not involve radiation. For a typical superficial lipoma, the combination of what your doctor feels and what the ultrasound shows is usually enough to make a confident diagnosis.

The situations where ultrasound findings should lead to additional workup are fairly specific: the mass is deep, large, irregularly shaped, growing, or has significant blood flow. In those cases your doctor will likely recommend MRI, a biopsy, or referral to a specialist, not because ultrasound failed but because it flagged something worth investigating further. For the majority of garden-variety lipomas, though, ultrasound provides the answer people are looking for: it is benign, it is not cancer, and no further testing is needed.